Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386147 · ClinicalTrials.gov registry record · NA
Flourish HEC to Prevent Recurrence of BV
A NA study of Bacterial Vaginosis, sponsored by Vaginal Biome Science.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT05386147: Completed NA study of Bacterial Vaginosis, sponsored by Vaginal Biome Science.
NCT05386147 is a NA study of Bacterial Vaginosis that has completed, run by Vaginal Biome Science. The registered enrollment target is 6 participants, below the 338-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05386147, a NA study of Bacterial Vaginosis, has completed, sponsored by Vaginal Biome Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
In a population of women with heightened vulvovaginal sensitivity and recurrent bacterial vaginosis (BV), the use of the Flourish HEC Vaginal Care System is being tested for prevention of BV recurrence over six months of use.
Primary Outcome
Vaginal swab will be analyzed by commercially available NGS service
Conditions Studied
Interventions
- DEVICE Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components)
Study Locations (1)
Pennsylvania
- Center for Pelvic Medicine - Rosemont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-12-22 |
| Est. Completion | 2022-11-15 |
| Phase | NA |
What the finished NCT05386147 record still lists
NCT05386147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 338-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention - of which Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components) is the first listed.
NCT05386147 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05386147 about?
NCT05386147 is a clinical study titled "Flourish HEC to Prevent Recurrence of BV". In a population of women with heightened vulvovaginal sensitivity and recurrent bacterial vaginosis (BV), the use of the Flourish HEC Vaginal Care System is being tested for prevention of BV recurrence over six months of use.
What is the current status of trial NCT05386147?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-12-22. Estimated completion is 2022-11-15.
What conditions does trial NCT05386147 study?
This clinical trial studies the following conditions: Bacterial Vaginosis.
What interventions are being tested in trial NCT05386147?
The interventions under investigation include: Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components) (DEVICE).
Who is sponsoring clinical trial NCT05386147?
This trial is sponsored by Vaginal Biome Science, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05386147 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05386147's enrollment target sits among peer trials
6 16th of 15 the lowest of 15 other Bacterial Vaginosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacterial Vaginosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Protocol CERN Feasibility Study
RECRUITING · NA
-
Vitamin D and Sexual Health
COMPLETED · NA
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI